Home / PCCB Knockout Cell Lines

PCCB Knockout Cell Lines

Gene: PCCB

Official Full Name: propionyl-CoA carboxylase subunit betaprovided by HGNC

Gene Summary: The protein encoded by this gene is a subunit of the propionyl-CoA carboxylase (PCC) enzyme, which is involved in the catabolism of propionyl-CoA. PCC is a mitochondrial enzyme that probably acts as a dodecamer of six alpha subunits and six beta subunits. This gene encodes the beta subunit of PCC. Defects in this gene are a cause of propionic acidemia type II (PA-2). Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO05418 PCCB Knockout cell line (HeLa) Human PCCB 1:3~1:6 Negative Online Inquiry
KO05419 PCCB Knockout cell line (HCT 116) Human PCCB 1:2~1:4 Negative Online Inquiry
KO05420 PCCB Knockout cell line (HEK293) Human PCCB 1:3~1:6 Negative Online Inquiry
KO05421 PCCB Knockout cell line (A549) Human PCCB 1:3~1:4 Negative Online Inquiry

Background

PCCB Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology designed to facilitate the study of the propionyl-CoA carboxylase beta subunit (PCCB) gene's role in cellular metabolism and disease. These cell lines are meticulously engineered to have the PCCB gene inactivated, enabling researchers to investigate the physiological consequences of PCCB deficiency, linked to various metabolic disorders including propionic acidemia.

The key function of these knockout cell lines lies in their ability to mimic pathological conditions by providing a reliable model for understanding the metabolic disruptions that occur in PCCB deficiency. Mechanistically, the absence of PCCB alters the carboxylation processes critical for the metabolism of certain amino acids and fatty acids, leading to the accumulation of toxic metabolites. This provides researchers with the unique opportunity to elucidate the underlying biochemical pathways, test compounds for therapeutic efficacy, and develop potential treatment strategies in a controlled laboratory environment.

The scientific importance of PCCB Gene Knockout Cell Lines is significant, particularly in the realms of research on metabolic diseases, pharmacology, and gene therapy. In clinical settings, these models can be instrumental in the assessment of novel drug candidates aimed at alleviating symptoms associated with PCCB-related disorders, thus accelerating the translation of findings from bench to bedside.

Compared to alternative models, such as wild-type or other knockout systems, PCCB Gene Knockout Cell Lines offer specificity and relevance to the study of PCCB functions. The precise genetic modification ensures that researchers are examining the direct consequences of PCCB loss, minimizing confounding factors that may arise from non-specific knockouts.

For researchers and clinicians seeking to advance their understanding of propionic acidemia and related metabolic pathways, PCCB Gene Knockout Cell Lines provide an invaluable resource. The ability to conduct targeted studies fosters innovation in treatment approaches and highlights the potential for discovery in metabolic research.

Our company specializes in the development of highly specific cell lines, ensuring the highest quality standards and reliable results. With a commitment to empowering scientific research, we provide comprehensive support and expertise in molecular biology tools, making us a trusted partner in your research endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.